Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort

Vaccines are the most effective means to prevent the potentially deadly effects of SARS-CoV-2 infection, but not all vaccinated individuals gain the same degree of protection. Patients undergoing chronic immunosuppressive therapy due to autoimmune diseases or liver transplants, for example, may show...

Descripción completa

Detalles Bibliográficos
Autores principales: Zecca, Erika, Rizzi, Manuela, Tonello, Stelvio, Matino, Erica, Costanzo, Martina, Rizzi, Eleonora, Casciaro, Giuseppe Francesco, Manfredi, Giulia Francesca, Acquaviva, Antonio, Gagliardi, Ileana, Calzaducca, Elisa, Mallela, Venkata Ramana, D’Onghia, Davide, Minisini, Rosalba, Bellan, Mattia, Castello, Luigi Mario, Gavelli, Francesco, Avanzi, Gian Carlo, Patrucco, Filippo, Chiocchetti, Annalisa, Pirisi, Mario, Rigamonti, Cristina, Lilleri, Daniele, Sola, Daniele, Sainaghi, Pier Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413351/
https://www.ncbi.nlm.nih.gov/pubmed/36016388
http://dx.doi.org/10.3390/v14081766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413351/
https://www.ncbi.nlm.nih.gov/pubmed/36016388
http://dx.doi.org/10.3390/v14081766

Ejemplares similares